kynurenine has been researched along with Muscle Weakness in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, T | 1 |
| Bopp, T | 1 |
| Ward, C | 1 |
| Notarangelo, FM | 1 |
| Schwarcz, R | 1 |
| Westbrook, R | 1 |
| Xue, QL | 1 |
| Walston, J | 1 |
| Hoke, A | 1 |
1 other study available for kynurenine and Muscle Weakness
| Article | Year |
|---|---|
Deletion of quinolinate phosphoribosyltransferase gene accelerates frailty phenotypes and neuromuscular decline with aging in a sex-specific pattern.
Topics: Aging; Animals; Female; Frailty; Kynurenine; Male; Mice; Muscle Weakness; Phenotype | 2023 |